Why the study?
Resonance breathing benefits health by stimulating the baroreflex and increasing cardiac vagal activity, but whether supplementing it with coherent pelvic floor activation yields stronger cardiac vagal activity was unknown.
Does resonance breathing with coherent pelvic floor activation increase cardiac vagal activity compared to standard resonance breathing in healthy individuals?
Does resonance breathing with coherent pelvic floor activation increase cardiac vagal activity compared to standard resonance breathing in healthy individuals?
Answers are grounded in this paper and cite their sources.
Supplementing resonance breathing with coherent pelvic floor activation significantly enhances cardiac vagal activity in healthy individuals.
Resonance breathing (RB) has been shown to benefit health and performance within clinical and non-clinical populations. This is attributed to its baroreflex stimulating effect and the concomitant increase in cardiac vagal activity (CVA). Hence, developing methods that strengthen the CVA boosting effect of RB could improve its clinical effectiveness. Therefore, we assessed whether supplementing RB with coherent pelvic floor activation (PRB), which has been shown to entrain the baroreflex, yields stronger CVA than standard RB. N = 32 participants performed 5-minutes of RB and PRB, which requires to recruit the pelvic floor during the complete inspiratory phase and release it at the initiation of the expiration. CVA was indexed via heart rate variability using RMSSD and LF-HRV. PRB induced significantly larger RMSSD (d = 1.04) and LF-HRV (d = 0.75, ps < .001) as compared to RB. Results indicate that PRB induced an additional boost in CVA relative to RB in healthy individuals. However, subsequent studies are warranted to evaluate whether these first findings can be replicated in individuals with compromised health, including a more comprehensive psychophysiological assessment to potentially elucidate the origin of the observed effects. Importantly, longitudinal studies need to address whether PRB translates to better treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Tatschl et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: